126 related articles for article (PubMed ID: 9255260)
21. Constitutional translocation t(1;17)(p36;q12-21) in a patient with neuroblastoma.
Laureys G; Speleman F; Opdenakker G; Benoit Y; Leroy J
Genes Chromosomes Cancer; 1990 Sep; 2(3):252-4. PubMed ID: 2078517
[TBL] [Abstract][Full Text] [Related]
22. Cytogenetic analysis of infantile neuroblastomas by comparative genomic hybridization.
Iehara T; Hamazaki M; Sawada T
Cancer Lett; 2002 Apr; 178(1):83-9. PubMed ID: 11849745
[TBL] [Abstract][Full Text] [Related]
23. Chromosomal analysis of neuroblastoma.
Hafez M; el-Meadday M; Sheir M; Al-Tonbarry Y; Nada N; el-Desoky I
Br J Cancer; 1985 Feb; 51(2):237-43. PubMed ID: 3966981
[TBL] [Abstract][Full Text] [Related]
24. Establishment of a new cell line, VA-N-BR, from a primitive neuroblastoma tumor of the abdomen.
Helson L; Helson C
Anticancer Res; 1992; 12(2):467-72. PubMed ID: 1580564
[TBL] [Abstract][Full Text] [Related]
25. Growth patterns of human neuroblastoma xenografts and their relationship to treatment outcome.
George BA; Yanik G; Wells RJ; Martin LW; Soukup S; Ballard ET; Gartside PS; Lampkin BC
Cancer; 1993 Dec; 72(11):3331-9. PubMed ID: 8242560
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells.
Kim CJ; Chi JG; Thiele CJ
Lab Invest; 1999 Aug; 79(8):1007-13. PubMed ID: 10462038
[TBL] [Abstract][Full Text] [Related]
27. In vivo karyotypic evolution with altered biological characteristics in a case of neuroblastoma.
Enomoto H; Nakamura Y; Kondo K; Hirose M; Kaneko Y; Horie H; Takahashi H; Ohnuma N; Tanabe M; Nakagawara A
J Pediatr Surg; 1998 Sep; 33(9):1404-7. PubMed ID: 9766365
[TBL] [Abstract][Full Text] [Related]
28. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
[TBL] [Abstract][Full Text] [Related]
29. Neuroblastoma. Effect of genetic factors on prognosis and treatment.
Brodeur GM; Azar C; Brother M; Hiemstra J; Kaufman B; Marshall H; Moley J; Nakagawara A; Saylors R; Scavarda N
Cancer; 1992 Sep; 70(6 Suppl):1685-94. PubMed ID: 1325279
[TBL] [Abstract][Full Text] [Related]
30. Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.
Ando K; Ohira M; Ozaki T; Nakagawa A; Akazawa K; Suenaga Y; Nakamura Y; Koda T; Kamijo T; Murakami Y; Nakagawara A
Int J Cancer; 2008 Nov; 123(9):2087-94. PubMed ID: 18726896
[TBL] [Abstract][Full Text] [Related]
31. Interphase fluorescence in situ hybridization detection of chromosome 17 and 17q region gains in neuroblastoma: are they secondary events?
Trakhtenbrot L; Cohen N; Betts DR; Niggli FK; Amariglio N; Brok-Simoni F; Rechavi G; Meitar D
Cancer Genet Cytogenet; 2002 Sep; 137(2):95-101. PubMed ID: 12393279
[TBL] [Abstract][Full Text] [Related]
32. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
33. Detection of single-copy chromosome 17q gain in human neuroblastomas using real-time quantitative polymerase chain reaction.
Morowitz M; Shusterman S; Mosse Y; Hii G; Winter CL; Khazi D; Wang Q; King R; Maris JM
Mod Pathol; 2003 Dec; 16(12):1248-56. PubMed ID: 14681326
[TBL] [Abstract][Full Text] [Related]
34. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
Godfried MB; Veenstra M; v Sluis P; Boon K; v Asperen R; Hermus MC; v Schaik BD; Voƻte TP; Schwab M; Versteeg R; Caron HN
Oncogene; 2002 Mar; 21(13):2097-101. PubMed ID: 11960382
[TBL] [Abstract][Full Text] [Related]
35. Translocation (19;?) in two stage II neuroblastomas.
Franke F; Rudolph B; Lampert F
Cancer Genet Cytogenet; 1986 Feb; 20(1-2):129-35. PubMed ID: 3943056
[TBL] [Abstract][Full Text] [Related]
36. N-myc amplification in multiple homogeneously staining regions in two human neuroblastomas.
Emanuel BS; Balaban G; Boyd JP; Grossman A; Negishi M; Parmiter A; Glick MC
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3736-40. PubMed ID: 2582423
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic features of human neuroblastomas and cell lines.
Brodeur GM; Green AA; Hayes FA; Williams KJ; Williams DL; Tsiatis AA
Cancer Res; 1981 Nov; 41(11 Pt 1):4678-86. PubMed ID: 6171342
[TBL] [Abstract][Full Text] [Related]
38. [Identification of the breakpoint-flanking markers on chromosomes 1 and 17 of a constitutional translocation T(1;17)(P36;Q12-21) in a patient with neuroblastoma].
Laureys GG
Verh K Acad Geneeskd Belg; 1995; 57(5):389-422. PubMed ID: 8571670
[TBL] [Abstract][Full Text] [Related]
39. Different karyotypic patterns in early and advanced stage neuroblastomas.
Kaneko Y; Kanda N; Maseki N; Sakurai M; Tsuchida Y; Takeda T; Okabe I; Sakurai M
Cancer Res; 1987 Jan; 47(1):311-8. PubMed ID: 3791218
[TBL] [Abstract][Full Text] [Related]
40. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma.
Christiansen H; Lampert F
Br J Cancer; 1988 Jan; 57(1):121-6. PubMed ID: 3348945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]